Disease Stability in Segmental and Non-Segmental Vitiligo

被引:2
|
作者
Taneja, Neha [1 ]
Sreenivas, V [2 ]
Sahni, Kanika [1 ]
Gupta, Vishal [1 ]
Ramam, M. [1 ]
机构
[1] All India Inst Med Sci, Dept Dermatol & Venereol, New Delhi 110029, India
[2] All India Inst Med Sci, Dept Biostat, New Delhi, India
关键词
Stability; vitiligo; reactivation;
D O I
10.4103/idoj.IDOJ_154_21
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Introduction: Some therapeutic decisions in vitiligo depend on the likelihood of the disease remaining stable and inactive. Aim: To determine a period of disease stability in vitiligo following which reactivation was unlikely. Materials and Methods: This cross-sectional descriptive study was carried out in 200 patients where a detailed clinical history of the disease activity and stability over the course of vitiligo was recorded. Results: There were 167 (83.5%) patients with non-segmental vitiligo and 33 (16.5%) with segmental vitiligo. For every 1-year increase in the duration of the disease, stable and active periods increased by 0.7 and 0.3 years, respectively in non-segmental vitiligo and by 0.9 and 0.1 years in segmental vitiligo (P < 0.01). When segmental vitiligo was stable for at least 2 years, it was five times less likely to re-activate than the disease that was stable for less than 2 years (P = 0.16). However, in non-segmental vitiligo, we found no association between the duration of stability and risk of reactivation. Conclusions: Segmental vitiligo usually becomes inactive after the disease has been stable for 2 years. Non-segmental vitiligo is prone to reactivation even after prolonged periods of stability.
引用
收藏
页码:60 / 63
页数:4
相关论文
共 50 条
  • [1] Antioxidant status of segmental and non-segmental vitiligo
    Shajil, EM
    Begum, R
    [J]. PIGMENT CELL RESEARCH, 2006, 19 (02): : 179 - 180
  • [2] Deregulation of chemotactic signals in segmental and non-segmental vitiligo
    El-Domyati, M.
    El-Din, W. Hosam
    Rezk, A. F.
    Uitto, J.
    Igoucheva, O.
    Kemp, D.
    Alexeev, V.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (05) : S109 - S109
  • [3] A COMPARATIVE CLINICAL-STUDY OF SEGMENTAL AND NON-SEGMENTAL VITILIGO
    HALDER, RM
    GRIMES, PE
    MINUS, HR
    ENTERLINE, JP
    CHAKRABARTI, SG
    KENNEY, JA
    [J]. CLINICAL RESEARCH, 1983, 31 (02): : A570 - A570
  • [4] Effects of age of onset on disease characteristics in non-segmental vitiligo
    Solak, Berna
    Dikicier, Bahar Sevimli
    Cosansu, Nur C.
    Erdem, Teoman
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2017, 56 (03) : 341 - 345
  • [5] Autoimmune thyroid disease in Italian patients with non-segmental vitiligo
    Meena Arunachalam
    Lisa Pisaneschi
    Roberta Colucci
    Federica Dragoni
    Rossana Conti
    Silvia Moretti
    [J]. European Journal of Dermatology, 2014, 24 : 625 - 626
  • [6] Autoimmune thyroid disease in Italian patients with non-segmental vitiligo
    Arunachalam, Meena
    Pisaneschi, Lisa
    Colucci, Roberta
    Dragoni, Federica
    Conti, Rossana
    Moretti, Silvia
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2014, 24 (05) : 625 - 626
  • [7] Excimer light photototherapy of segmental and non-segmental vitiligo: experience in Taiwan
    Cheng, Yu-Pin
    Chiu, Hsien-Yi
    Jee, Shiou-Hwa
    Tsai, Tsen-Fang
    [J]. PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2012, 28 (01) : 6 - 11
  • [8] Superimposed segmental vitiligo (mixed vitiligo) with non-segmental vitiligo and segmental vitiligo along the narrow Blaschko lines (type 1a)
    Oiso, Naoki
    Kawada, Akira
    [J]. JOURNAL OF DERMATOLOGY, 2016, 43 (11): : 1388 - 1389
  • [9] Review of Ruxolitinib for Treatment of Non-Segmental Vitiligo
    Hwang, Jacqueline R. R.
    Driscoll, Marcia S. S.
    [J]. ANNALS OF PHARMACOTHERAPY, 2023, 57 (08) : 948 - 955
  • [10] Segmental vitiligo as the possible expression of cutaneous somatic mosaicism: implications for common non-segmental vitiligo
    Taieb, Alain
    Morice-Picard, Fanny
    Jouary, Thomas
    Ezzedine, Khaled
    Cario-Andre, Muriel
    Gauthier, Yvon
    [J]. PIGMENT CELL & MELANOMA RESEARCH, 2008, 21 (06) : 646 - 652